Dr. Bassem Razzouk, MD

NPI: 1124021829
Total Payments
$46,110
2024 Payments
$20,831
Companies
21
Transactions
82

Payment Breakdown by Category

Other$35,110 (76.1%)
Travel$5,681 (12.3%)
Food & Beverage$2,957 (6.4%)
Consulting$2,200 (4.8%)
Education$161.90 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,110 10 76.1%
Travel and Lodging $5,681 14 12.3%
Food and Beverage $2,957 54 6.4%
Consulting Fee $2,200 2 4.8%
Education $161.90 2 0.4%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $43,815 42 $0 (2024)
SOBI, INC $458.34 6 $0 (2024)
TerSera Therapeutics LLC $400.00 1 $0 (2022)
Rigel Pharmaceuticals, Inc. $245.99 3 $0 (2023)
Amgen Inc. $164.58 3 $0 (2024)
Incyte Corporation $159.21 2 $0 (2023)
Foundation Medicine, Inc. $153.20 2 $0 (2022)
Fennec Pharmaceuticals, Inc. $148.01 3 $0 (2024)
Genentech, Inc. $127.05 1 $0 (2023)
Seagen Inc. $76.63 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $20,831 16 JAZZ PHARMACEUTICALS INC. ($20,485)
2023 $2,970 21 JAZZ PHARMACEUTICALS INC. ($1,878)
2022 $560.24 3 TerSera Therapeutics LLC ($400.00)
2021 $23.65 1 Amgen Inc. ($23.65)
2019 $149.00 4 Rigel Pharmaceuticals, Inc. ($100.33)
2018 $17,532 22 Jazz Pharmaceuticals Inc. ($17,480)
2017 $4,044 15 Jazz Pharmaceuticals Inc. ($3,972)

All Payment Transactions

82 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/10/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,790.00 General
Category: HEMATOLOGY/ONCOLOGY
11/28/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,580.00 General
Category: HEMATOLOGY/ONCOLOGY
11/22/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Travel and Lodging In-kind items and services $1,461.82 General
Category: HEMATOLOGY/ONCOLOGY
11/15/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Food and Beverage In-kind items and services $131.03 General
Category: HEMATOLOGY/ONCOLOGY
10/15/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $121.18 General
Category: Oncology
09/05/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Travel and Lodging In-kind items and services $526.96 General
Category: HEMATOLOGY/ONCOLOGY
08/14/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,340.00 General
Category: HEMATOLOGY/ONCOLOGY
08/10/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Travel and Lodging In-kind items and services $1,039.52 General
Category: HEMATOLOGY/ONCOLOGY
08/08/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Food and Beverage In-kind items and services $126.00 General
Category: HEMATOLOGY/ONCOLOGY
08/08/2024 SOBI, INC GAMIFANT (Drug) Food and Beverage In-kind items and services $123.49 General
Category: HEMATOLOGY
08/06/2024 SOBI, INC GAMIFANT (Drug) Education In-kind items and services $80.95 General
Category: HEMATOLOGY
03/20/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,340.00 General
Category: HEMATOLOGY/ONCOLOGY
03/20/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Travel and Lodging In-kind items and services $15.00 General
Category: HEMATOLOGY/ONCOLOGY
03/20/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Travel and Lodging In-kind items and services $14.74 General
Category: HEMATOLOGY/ONCOLOGY
03/08/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Food and Beverage In-kind items and services $120.19 General
Category: HEMATOLOGY/ONCOLOGY
01/31/2024 Fennec Pharmaceuticals, Inc. Pedmark (Drug) Food and Beverage In-kind items and services $20.22 General
Category: Cisplatin-induced Ototoxicity
11/14/2023 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $121.36 General
Category: Acute Myeloid Leukemia
11/13/2023 RARE DISEASE THERAPEUTICS, INC. PURIXAN (Drug) Food and Beverage In-kind items and services $47.64 General
Category: Oncology
10/30/2023 SERVIER PHARMACEUTICALS LLC Asparlas (Drug), Oncaspar Food and Beverage In-kind items and services $18.52 General
Category: Oncology
09/27/2023 SOBI, INC Gamifant (Drug) Education In-kind items and services $80.95 General
Category: HEMATOLOGY
09/15/2023 SOBI, INC Gamifant (Drug) Food and Beverage In-kind items and services $28.15 General
Category: HEMATOLOGY
09/13/2023 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,860.00 General
Category: HEMATOLOGY/ONCOLOGY
09/01/2023 Fennec Pharmaceuticals, Inc. Pedmark (Drug) Food and Beverage In-kind items and services $10.33 General
Category: cisplatin-induced ototoxicity
06/27/2023 Y-mAbs Therapeutics, Inc. DANYELZA (Drug) Food and Beverage Cash or cash equivalent $24.53 General
Category: Oncology
06/20/2023 Bayer Healthcare Pharmaceuticals Inc. Vitrakvi (Drug) Food and Beverage In-kind items and services $32.50 General
Category: Oncology

About Dr. Bassem Razzouk, MD

Dr. Bassem Razzouk, MD is a Pediatric Hematology-Oncology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124021829.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bassem Razzouk, MD has received a total of $46,110 in payments from pharmaceutical and medical device companies, with $20,831 received in 2024. These payments were reported across 82 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,110).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Indianapolis, IN
  • Active Since 05/27/2005
  • Last Updated 04/11/2012
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1124021829

Products in Payments

  • RYLAZE (Drug) $22,363
  • Erwinaze (Drug) $17,326
  • Gamifant (Drug) $253.90
  • GAMIFANT (Drug) $204.44
  • Blincyto (Biological) $164.58
  • JAKAFI (Drug) $159.21
  • FOUNDATIONONE (Device) $153.20
  • Pedmark (Drug) $148.01
  • Rezlidhia (Drug) $145.66
  • Tavalisse (Drug) $100.33
  • Defitelio (Drug) $88.99
  • ADCETRIS (Biological) $76.63
  • CALQUENCE (Drug) $59.95
  • Vitrakvi (Drug) $48.69
  • PURIXAN (Drug) $47.64
  • Asparlas (Drug) $37.33
  • Xatmep (Drug) $34.15
  • JADENU (Drug) $33.54
  • DANYELZA (Drug) $24.53
  • AKYNZEO (Drug) $24.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Indianapolis